Skip to content

Prognostic Factors Influencing the Recurrence Rate and Survival of Patients With Colorectal Cancer: a Single Institution Experience

Prognostic Factors Influencing the Recurrence Rate and Survival of Patients With Colorectal Cancer: a Single Institution Experience

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06325410
Enrollment
200
Registered
2024-03-22
Start date
2013-01-31
Completion date
2022-12-31
Last updated
2024-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

colorectal, cancer, recurrence, prognosis

Brief summary

over the past decade colon cancer has emerged as the second most deadly and the third most common type of cancer in the world with increasing incidence in Egypt due to life style and diet change. some research showed relation between colon cancer recurrence and advanced tumor staging. To investigators knowledge, this is the first time to be done in Zagazig University. Data was collected from records in a retrospective cohort study

Interventions

PROCEDUREresection of colorectal cancer

resection of bowel segment and re-anastmosis or stoma formation

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Adult patients with newly diagnosed colorectal cancer * Age \> 18 years old * recurrent cases of colorectal cancer

Exclusion criteria

* Pediartric patient less than 18 yr * In operable or metastatic cancer colon * No other malignancies

Design outcomes

Primary

MeasureTime frameDescription
agethrough study completion, an average of 5 yearsage of patients was obtained from medical records
sexthrough study completion, an average of 5 yearssex of patients was obtained from medical records
medical diseasethrough study completion, an average of 5 yearsco-existing medical disease was obtained from medical records
previous surgerythrough study completion, an average of 5 yearsprevious surgical history was obtained from medical records
CEAthrough study completion, an average of 5 yearsvalue of carcino-embryonic antigen was recorded
tumor gradethrough study completion, an average of 5 yearstumor grade after resection from pathology report recorded
tumor sitethrough study completion, an average of 5 yearstumor site recorded from operative findings
tumor sizethrough study completion, an average of 5 yearstumor size was measured by length x width in cm from records
surgical margins of resected tumorthrough study completion, an average of 5 yearssafety margins were assessed from pathological examination under microscopy and recorded in pathology reports, it can be free surgical margins ( no tumor cells) or positive surgical margins( presence of tumor cells)
neoadjuvant therapythrough study completion, an average of 5 yearshistory of neoadjuvant therapy before surgery from records obtained
adjuvant therapythrough study completion, an average of 5 yearshistory of adjuvant therapy post operative obtained from records
dietthrough study completion, an average of 5 yearsdiet and dietary life style from history
occupationthrough study completion, an average of 5 yearsoccupation of the patient at time of surgery and if it was changed
family historythrough study completion, an average of 5 yearshistory taking of family history of cancer disease
type of surgery(laparoscopic or open)through study completion, an average of 5 yearstype of operation was laparoscopic or open surgery obtained from records
soiling by during surgerythrough study completion, an average of 5 yearsby history from records if there was soiling of the field by tumor cells
hand sewen or stappled anastmosisthrough study completion, an average of 5 yearsif there was bowel re-anastmosis after surgery, it was done using a stappler or hand sewing sutures. this was obtained from operative data in patient records
post operative complicationsthrough study completion, an average of 5 yearsfrom records; if there were post operative complication like fecal fistula
site of recurrencethrough study completion, an average of 5 yearssite of tumor recurrence was detected
type of resected tumorthrough study completion, an average of 5 yearstype of tumor was recorded from pathology reports

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026